Partner News: Progenity Raises $125M in Series B Financing to Advance Dx-Rx Platform for GI Tract

Progenity said today it has raised $125 million in Series B financing toward expanding its focus beyond women’s health by accelerating the development of its precision diagnostics and therapeutics platform for the gastrointestinal (GI) tract.

To read more, please click: